Growth hormone polypeptides and methods of making and using same

Details for Australian Patent Application No. 2010258892 (hide)

Owner Amunix Operating Inc.

Inventors Schellenberger, Volker; Silverman, Joshua; Stemmer, Willem P.; Wang, Chia-Wei; Geething, Nathan; Cleland, Jeffrey L.

Agent Pizzeys

Pub. Number AU-A-2010258892

PCT Pub. Number WO2010/144502

Priority 61/185,112 08.06.09 US; 12/699,761 03.02.10 US; 61/280,955 10.11.09 US; 61/236,836 25.08.09 US; PCT/ US2010/023106 03.02.10 US

Filing date 8 June 2010

Wipo publication date 16 December 2010

International Classifications

C07K 14/46 (2006.01) Peptides having more than 20 amino acids

A61K 38/16 (2006.01) Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/23 (2006.01) Medicinal preparations containing peptides - Calcitonins

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/31 (2006.01) Medicinal preparations containing peptides - Somatostatins

A61K 38/36 (2006.01) Medicinal preparations containing peptides - Blood coagulation or fibrinolysis factors

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/08 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/06 (2006.01) Drugs for disorders of the endocrine system

A61P 5/22 (2006.01) Drugs for disorders of the endocrine system

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61P 19/02 (2006.01) Drugs for skeletal disorders

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/61 (2006.01) Peptides having more than 20 amino acids

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/144502 Priority application(s): WO2010/144502

21 June 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Schellenberger, Volker; Silverman, Joshua; Stemmer, Willem P.; Wang, Chia-Wei; Geething, Nathan; Cleland, Jeffrey L. and Spink, Benjamin

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010258893-Antimicrobial textiles comprising peroxide

2010258891-Containment systems